Emergence of cytomegalovirus disease in patients receiving temozolomide: Report of two cases and literature review

Clinical Infectious Diseases

Volumn 50, Issue 12, 2010, Pages

  Meije, Yolanda ^a   Lizasoain, Manuel ^a   García Reyne, Ana ^a   Martínez, Pilar ^a   Rodríguez, Virginia ^a   López Medrano, Francisco ^a   Juan, Rafael San ^a   Lalueza, Antonio ^a   Aguado, José María ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; COLISTIN; CORTICOSTEROID; COTRIMOXAZOLE; CYTOMEGALOVIRUS ANTIGEN PP65; DEXAMETHASONE; DOXORUBICIN; EXTENDED SPECTRUM BETA LACTAMASE; GANCICLOVIR; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; RITUXIMAB; TEMOZOLOMIDE; THALIDOMIDE; VALGANCICLOVIR;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; B CELL LYMPHOMA; BACTERIAL SUPERINFECTION; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM TUMOR; COLITIS; COLON ULCER; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ESCHERICHIA COLI; FEMALE; GASTROINTESTINAL INFECTION; GLIOBLASTOMA; HOSPITALIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION PREVENTION; INTERSTITIAL PNEUMONIA; LYMPHOCYTOPENIA; MALE; MEDICAL RECORD REVIEW; MENINGITIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RECTUM HEMORRHAGE; RISK FACTOR; TREATMENT DURATION;

AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; CENTRAL NERVOUS SYSTEM NEOPLASMS; CYTOMEGALOVIRUS INFECTIONS; DACARBAZINE; FEMALE; GLIOBLASTOMA; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS;

EID: 77953010335     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/653011     Document Type: Article

References (16)

1. Cohen MH, Johnson JR, Pazdur R. Food and Drug Administration Drug approval summary: temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme. Clin Cancer Res 2005; 11(19 Pt 1): 6767-6771. (Pubitemid 41428729)
2. Newlands ES, Stevens MF, Wedge SR, Wheelhouse RT, Brock C. Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat Rev 1997; 23(1): 35-61. (Pubitemid 27273454)
3. Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009; 10(5): 459-466.
4. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352(10): 987-996. (Pubitemid 40349501)
5. Newlands ES, Blackledge GR, Slack JA, et al. Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856). Br J Cancer 1992; 65(2): 287-291.
6. Berrocal A, Perez Segura P, Gil M, et al. Extended-schedule dose-dense temozolomide in refractory gliomas. J Neurooncol 2010; 96(3): 417-422.
7. Stupp R, Dietrich PY, Ostermann Kraljevic S, et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 2002; 20(5): 1375-1382. (Pubitemid 34177445)
8. + lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications. J Clin Oncol 2004; 22(4): 610-616.
9. Yu SK, Chalmers AJ. Patients receiving standard-dose temozolomide therapy are at risk of Pneumocystis carinii pneumonia. Clin Oncol (R Coll Radiol) 2007; 19(8): 631-632.
10. Damek DM, Lillehei KO, Kleinschmidt-DeMasters BK. Aspergillus terreus brain abscess mimicking tumor progression in a patient with treated glioblastoma multiforme. Clin Neuropathol 2008; 27(6): 400-407.
11. Choi JD, Powers CJ, Vredenburgh JJ, Friedman AH, Sampson JH. Cryptococcal meningitis in patients with glioma: a report of two cases. J Neurooncol 2008; 89(1): 51-53.
12. Schwarzberg AB, Stover EH, Sengupta T, et al. Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide. Cancer Invest 2007; 25(4): 249-255. (Pubitemid 47026948)
13. Yaman E, Coskun U, Ozturk B, et al. Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma. J Clin Neurosci 2009; 16(4): 591-592.
14. De Jesus A, Grossman SA, Paun O. Cytomegalovirus associated colonic pseudotumor: a consequence of iatrogenic immunosuppression in a patient with primary brain tumor receiving radiation and temozolomide. J Neurooncol 2009; 94(3): 445-448.
15. Douzinas EE, Flevari K, Andrianakis I, Betrosian AP. Oral atovaquone for the treatment of severe Pneumocystis jirovecii pneumonia in a patient with glucose-6-phosphate dehydrogenase deficiency. Scand J Infect Dis 2010; 42(1): 76-78.
16. Rietschel P, Wolchok JD, Krown S, et al. Phase II study of extendeddose temozolomide in patients with melanoma. J Clin Oncol 2008; 26(14): 2299-2304.